-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Mar 14, 16:00Prev. Close
396.55
Open Price
395.10
Bid Price (Qty.)
395.00 (1000)
Offer Price (Qty.)
396.55 (187)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Claris Lifesciences (in Rs. Cr.) | Dec 11 | Dec 10 | Dec 09 | Dec 08 | Dec 07 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 94.92 | 97.73 | 102.27 | 145.55 | 113.66 | |
| Net CashFlow From Operating Activities | 62.32 | 110.24 | 187.37 | 171.52 | 38.47 | |
| Net Cash Used In Investing Activities | -204.03 | -143.99 | -103.74 | -205.00 | -137.80 | |
| Net Cash Used From Financing Activities | -24.07 | 280.86 | -56.76 | 35.89 | 37.16 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -165.79 | 247.11 | 26.87 | 2.40 | -62.17 | |
| Cash And Cash Equivalents Begin of Year | 279.83 | 43.53 | 16.67 | 14.26 | 76.43 | |
| Cash And Cash Equivalents End Of Year | 114.04 | 290.64 | 43.53 | 16.67 | 14.26 |
03.12.2017
17.10.2017
31.07.2017
US FDA conducts surprise audit at Claris Life's Ahmedabad unit
27.07.2017
Claris completes injectables biz sale, to inform about transfer to shareholders by Oct
